Coty has decided that the surest way into women’s perfume is a men’s cologne it has sold since 1998. Boss Bottled, past 100 million bottles, is getting its first women’s edition this autumn; the house is mining equity it owns rather than building more. Women account for over 70% of global perfume revenue, per Grand View Research, so the prize was never in doubt; only the cost of reaching it was. Coty’s brand chief calls Boss Bottled “almost a brand within a brand,” the candid name for the plan.

Clinique is running the same play in makeup. Black Honey, a sheer lip shade it introduced in 1971, is now spun across nail polish, mascara and an eyeshadow quad in a limited-edition run available for six months; it is the best-selling prestige lipstick in five countries. The extension arrives with a Times Square billboard and a newly minted holiday, Almost Lipstick Day, on 28 July; Clinique’s makeup net sales fell double-digits in the most recent quarter. A shade older than most of its buyers is being sold as this summer’s arrival.

Rack & Reason has traced the mechanics before, when Marc Jacobs rebuilt a makeup line on a 2007 bottle cap. The move here is colder. Coty and Clinique are not reviving dormant names. They are giving their top sellers the full apparatus of a launch: a celebrity campaign, a billboard, an invented holiday. Beneath it sits no new brand at all. Beauty did not stop launching. It stopped building the thing a launch used to announce.

That cost now sets the price of everything. The era of buying customers at any cost is ending; beauty’s affiliate conversion rate has slipped to 2.8%, and brands are trading reach for performance accountability. A name the shopper already trusts needs no introduction, and introduction is where the budget now goes.

The houses treat this as arithmetic, and they are proud of it. Coty’s prestige fragrance has compounded at 10% a year between fiscal 2021 and 2025, built on names it manages rather than invents. When the growth already lives in the franchise, the franchise is what you extend.

The deal tables tell the same story. Beauty logged 263 transactions in 2025, down 11.5% on the year, with capital chasing scale over novelty. The industry has stopped funding debut albums and started buying back the catalogue.

The other side of that ledger is the closures. Beauty’s 2025 casualties ran from L’Oréal-backed newcomers like Ami Colé to REN, a “clean” brand large enough to look safe. The trade press blamed a saturated market. A crowded shelf does not punish bad products; it punishes unknown ones.

What the industry manufactures now is not a new product — it is the feeling of one.

The houses prefer a warmer account. Clinique’s Anna Vitale calls Black Honey “more than a shade” that has “almost become a personality,” and cites innovation fatigue as rationale for returning to what is “true and trusted.” But she has named a symptom and called it a strategy.

A catalogue is finite. Every shade re-sold and every scent re-gendered draws down equity that no new launch is replacing. Every franchise in this strategy was built decades ago, when the market still paid for building. Beauty has learned to grow without building; it has not yet said what it sells once the catalogue runs out.